---
title: "LMWH in Renal Insufficiency"
subtitle: "Sample Size Calculations"
output: pdf_document
date: '`r format(Sys.Date(), "%B %d, %Y")`'
---

## Sample Size Calculations

### Potential Assumptions
Using the results from: DeCarolis, et al. Arch Intern Med. 2012;172:1713-1718

* CrCl >80 mL/min: 5.7%
* CrCl 30-50 mL/min: 22.0%

```{r}
power.prop.test(p1=0.057, p2=0.22, power=0.8, alternative="two.sided")
```

Using results from meta-analysis: Hoffmann, et al. Eur J Clin Pharmacol. 2012;68:757â€“765

* CrCl >60 mL/min: 
* CrCl <60 mL/min:

__Note:__ This included enoxaparin use in ACS

```{r}
power.prop.test(p1=0.036, p2=0.065, power=0.8, alternative="two.sided")
```

Using the risk of bleeding from package insert (2%) and assuming a 5%, 10%, or 15% difference:

```{r}
power.prop.test(p1=0.02, p2=0.07, power=0.8, alternative="two.sided")
power.prop.test(p1=0.02, p2=0.12, power=0.8, alternative="two.sided")
power.prop.test(p1=0.02, p2=0.17, power=0.8, alternative="two.sided")
```

### Recommended Assumption

Major bleeding with enoxaparin has been reported at 2 - 5.7%.

Major bleeding with a CrCl <60 mL/min or between 30-50 mL/min has been reported at 6.5% and 22.0%, respectively.

Using the mean of these two values (`r mean(c(0.02, 0.057))`) and (`r mean(c(0.065, 0.22))`) gives us:

```{r}
power.prop.test(p1=mean(c(0.02, 0.057)), p2=mean(c(0.065, 0.22)), power=0.8, alternative="two.sided")
```

